Previous Page  33 / 56 Next Page
Information
Show Menu
Previous Page 33 / 56 Next Page
Page Background

Neumol Pediatr 2018; 13 (4): 149 - 163

C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl

162

Terapia inhalatoria en pacientes que reciben ventilación mecánica

drugs. Respir Care 2011;56:1411-21.

24. Myers T. The science guiding selection of an aerosol delivery

device. Respir Care 2013;58;1963-73.

25. Berlinski A, Cooper B. Oronasal and tracheostomy delivery of

soft mist and pressurized metered-dose inhalers with valved

holding chamber. Respir Care 2016;61:913-9.

26. Dellweg D, Watchel H, Hön E, Pieper M, Barfcheld T, Khöler D,

et al. In vitro validation of a Respimat® adapter for delivery

of inhaled bronchodilators during mechanical ventilation. J

Aerosol Med Pulm Drug Deliv 2011;24:285-92.

27. Smyth H. The influence of formulation variables on the

performance of alternative propellant-driven metered dose

inhalers. Adv Drug Deliv Rev. 2003;55:807-28.

28. Newman S. Principles of metered-dose inhaler design.

Respir Care 2005;50-1177-88.

29. Roche N, Dekhuijzen P. The evolution of pressurized metered-

dose inhalers from early to modern devices. J Aerosol Med

Pulm Drug Deliv 2016;29:311-27.

30. Stein S, Sheth P, Hodson P, Myrdal P. Advances in metered

dose inhaler technology: hardware development. AAPS

PharmSciTech 2014;15:326-8.

31. Myrdal P, Sheth P, Stein S. Advances in metered dose inhaler

technology: formulation development. AAPS PharmSciTech

2014;15:434-55.

32. Iñiguez F. Terapia inhalatoria en los pacientes con

ventilación mecánica domiciliaria. Neumologia Pediatrica

2008;3(sup.1):87-99. Disponible en:

h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . c l / / wp c o n t e n t /

uploads/2017/06/TerapiaInhalatoria.pdf

33. Hendeless L, Colice G, Meyer R. Withdrawal of albuterol

inhalers containing chlorofluorocharbon propellants. N Engl

J Med 2007;356;1344-51.

34. Leach L. The CFC to HFA transition and its impact on

pulmonary drug development. Respir Care 2005;50:1201-6.

35. Hess D. Aerosol delivery devices in the treatment of asthma.

Respir Care 2008;53:699-725.

36. Dolovich M, Dhand R. Aerosol drug delivery: developments in

device design and clinical use. Lancet 2011;377:1032-45.

37. Dhand R. Basic techniques for aerosol delivery during

mechanical ventilation. Respir Care 2004;49:611-22.

38. Dhand R. Inhalation therapy with metered-dose inhalers

and dry powder inhalers in mechanically ventilated patients.

Respir Care 2005;50:1331-34.

39. Dhand R, Mercier E. Effective inhaled drug administration

to mechanically ventilated patients. Expert Opin Drug Deliv

2007;4:47-61.

40. Dhand R, Guntur V. How to best delivery aerosol medications

to mechanically ventilated patients. Clin Chest Med

2008;29:277-96.

41. Dhand R. Aerosol delivery during mechanical ventilation:

from basic techniques to new devices. J Aerosol Med Pulm

Drug Deliv. 2008;21:45-60

42. Ari A. Aerosol therapy in pulmonary critical care. Respir Care

2015;60:858-79.

43. Rubin B, Williams R. Emerging aerosol drug delivery

strategies: from bench to clinic. Adv Drug Deliv Rev

2014;75:141-8.

44. Dhand R. How should aerosols be delivered during invasive

mechanical ventilation? Respir Care 2017;62:1343-67.

45. Dugernier J, Ehrmann S, Sottiaux T, Roeseler J, Wittebole

X, Dugernier T, et al. Aerosol delivery during invasive

mechanical ventilation: a systematic review. Critical Care

2017;21:264.

46. Fink J, Dhand R, Grychowski J, Fahey P, Tobin M. Reconciling

in vitro and in vivo measurements of aerosol delivery from

a metered-dose inhaler during mechanical ventilation and

defining efficiency-enhancing factors. Am J Respir Crit Care

Med 1999;159:63-8.

47. Chatmongkolchart S, Schettino G, Dillman C, Kacmarek R,

Hess D. In vitro evaluation of aerosol bronchodilator delivery

during noninvasive positive pressure ventilation: effect of

ventilator settings and nebulizer position. Crit Care Med

2002;30:2515-9.

48. Lin HL, Restrepo R, Gardenhire D, Rau J. Effect of face

mask design on inhaled mass of nebulized albuterol, using a

pediatric breathing model. Respir Care 2007;52:1021-6.

49. Newman S, Chan H. In vitro/in vivo comparisons in pulmonary

drug delivery. J Aerosol Med Pulm Drug Deliv 2008;21:77-

84.

50. Ari A, Atalay O, Harwood R, Sherad M, Aljamhan E, Fink J.

Influence of nebulizer type, position, and bias flow on aerosol

drug delivery in simulated pediatric and adult lung models

during mechanical ventilation. Respir Care 2010;55:841-

51.

51. Sidler-Moix A, Di Paolo E, Dolci U, Berger-Gryllaki M, Cotting

J, Pannatier A. Physicochemical aspects and efficiency of

albuterol nebulization: comparison of three aerosol types in

an in vitro pediatric model. Respir Care 2015;60:38-46.

52. Berlinski A, Willis R. Effect of tidal volume and nebulizer type

and position on albuterol delivery in a pediatric model of

mechanical ventilation. Respir Care 2015;60:1424-30.

53. Cole C. Special problems in aerosol delivery: neonatal and

pediatric considerations. Respir Care 2000;45:646-51.

54. Mazela J, Polin R. Aerosol delivery to ventilated newborn

infants: historical challenges and new directions. Eur J

Pediatr 2011;170:433-44.

55. Mazela J, Merritt T, Finer N. Aerosolized surfactants. Curr

Opin Pediatr 2007;19:155-62.

56. DiBlasi R. Clinical controversies in aerosol therapy for

infants and children. Respir Care 2015;60:894-916.

57. Berlinski A. Pediatric Aerosol Therapy. Respir Care

2017;62:662-77.

58. Fink J. Aerosol delivery to ventilated infant and pediatric

patients. Respir Care 2004;49:653-65.

59. Iñiguez F, Sánchez I. Desarrollo Pulmonar. Neumologia

Pediatrica 2008;3:148-55. Disponible en: http://www.

neumologia-pediatrica.cl//wp-content/uploads/2017/06/

DesarrolloPulmonar.pdf

60. Guerin C, Fassier T, Bayle F, Lemasson S, Richard J. Inhaled

bronchodilator administration during mechanical ventilation:

how to optimize it, and for wich clinical benefit?. J Aerosol

Med Pulm Drug Deliv. 2008;21:85-95.

61. Ari A, Areaby H, Fink J. Evaluation of aerosol generator

devices at 3 locations in humidified and non-humidified

circuits during adult mechanical ventilation. Respir Care

2010;55:837-44.

62. Di Blassi R. Clearing the mist from our eyes: bronchodilators,

mechanical ventilation, new devices, locations, and what you